Complement activation has important physiological and pathological implications for kidney-related and other diseases. Here, the authors discuss the state of the art of complement therapeutics, including the targets, candidate drugs, insights from clinical trials and evolving challenges for the field.
- Daniel Ricklin
- Dimitrios C. Mastellos
- John D. Lambris